280 related articles for article (PubMed ID: 23682923)
1. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
Roberts DJ; Hall RI
Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic changes in critical illness.
Boucher BA; Wood GC; Swanson JM
Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic considerations in critically ill patients].
Escobar L; Gai MN; Regueira T; Andresen M
Rev Med Chil; 2012 Jun; 140(6):780-8. PubMed ID: 23282618
[TBL] [Abstract][Full Text] [Related]
4. Drug dosing considerations for the critically ill patient with liver disease.
Lin S; Smith BS
Crit Care Nurs Clin North Am; 2010 Sep; 22(3):335-40. PubMed ID: 20691384
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacology in the Intensive Care Unit patient.
Zagli G; Tarantini F; Bonizzoli M; Di Filippo A; Peris A; De Gaudio AR; Geppetti P
Fundam Clin Pharmacol; 2008 Oct; 22(5):493-501. PubMed ID: 18684127
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of Orally Administered Drugs in Critically Ill Patients.
Forsberg J; Bedard E; Mahmoud SH
J Pharm Pract; 2023 Aug; 36(4):967-979. PubMed ID: 35521821
[TBL] [Abstract][Full Text] [Related]
7. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.
Hites M; Dell'Anna AM; Scolletta S; Taccone FS
Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics in the critically ill child.
Zuppa AF; Barrett JS
Pediatr Clin North Am; 2008 Jun; 55(3):735-55, xii. PubMed ID: 18501763
[TBL] [Abstract][Full Text] [Related]
9. Clinical Pharmacology Studies in Critically Ill Children.
Thakkar N; Salerno S; Hornik CP; Gonzalez D
Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of linezolid in critically ill patients.
Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
[TBL] [Abstract][Full Text] [Related]
11. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Roberts JA; Lipman J
Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
[TBL] [Abstract][Full Text] [Related]
12. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.
Papadopoulos J; Smithburger PL
Crit Care Med; 2010 Jun; 38(6 Suppl):S126-35. PubMed ID: 20502166
[TBL] [Abstract][Full Text] [Related]
13. Approaches for dosage individualisation in critically ill patients.
del Mar Fernández de Gatta M; Martin-Suarez A; Lanao JM
Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1481-93. PubMed ID: 23898816
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
Velenosi TJ; Urquhart BL
Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
[TBL] [Abstract][Full Text] [Related]
15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of drugs used in critically ill adults.
Power BM; Forbes AM; van Heerden PV; Ilett KF
Clin Pharmacokinet; 1998 Jan; 34(1):25-56. PubMed ID: 9474472
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
[TBL] [Abstract][Full Text] [Related]
18. [Personalised pharmacotherapy in intensive care unit patients].
Bellmann R
Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of oral drug absorption processes in children.
Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
[TBL] [Abstract][Full Text] [Related]
20. Childhood obesity: Pharmacokinetics considerations for drugs used in the Intensive Care Unit.
Donoso F A; Ulloa V D; Contreras E D; Arriagada S D
Arch Argent Pediatr; 2019 Apr; 117(2):e121-e130. PubMed ID: 30869490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
